Valentis Pockets $14M in Public Offering

genomeweb
360dx

Valentis Pockets $14M in Public Offering

Dec 27, 2001

NEW YORK, Dec. 27 - Valentis has pocketed $13.8 million in an underwritten public offering of its common stock, the company said on Thursday.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Tourette Disorder Risk Genes, Pathways Emerge From Expanded Trio Analysis
IQuity Wins $320K NIH Grant to Develop Alzheimer's Diagnostic Tech
Researchers Use ZFNs to Edit Mutation in Mitochondrial DNA In Vivo
Single-Cell Analysis Uncovers Thousands of CNVs That Arise During Development
Acute Sleep Deprivation Linked to Shift in Blood-Based Gene Expression
Genome of Medieval Relapsing Fever Pathogen Provides Insights Into Microbe's Evolution

The Scan

Marks Left on the Genome

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

Cost and Coverage of Gene Therapies

The Wall Street Journal looks into the cost of new gene therapies.

Mosquito Population Crash

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

This Week in PNAS

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

Main menu